Skip to main content

Nugen Medical Devices Inc(NGMD-X)
TSX Venture

Today's Change
Delayed Last Update
Day Low0.030
Day High0.030
Open:0.030
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

Top Stories: Nugen Medical Devices Inc

Select a category then submit the form to load news
Newsfile
NuGen Medical Devices Inc. Provides Update on Health Canada License
Newsfile
NuGen Medical Devices Inc. Announces CFO Transition
Newsfile
NuGen Medical Devices Provides 2025 Year End Update on R&D and Strategic Progress
AI-generated - The Globe and Mail
NuGen Medical Devices: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (NGMD)
Newsfile
NuGen Medical Devices Announces NHS Drug Tariff Approval for EziAutoJector(R) Product Line in the UK
Newsfile
NuGen Medical Devices Announces New Needle-Free Injection System Featuring Internal Cartridge Technology
AI-generated - The Globe and Mail
NuGen Medical Devices: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (NGMD)
Newsfile
InsuJet Distribution Expands Across France
AI-generated - The Globe and Mail
NuGen Medical Devices: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (NGMD)
AI-generated - The Globe and Mail
NuGen Medical Devices: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (NGMD)
Newsfile
NuGen Announces Release of 2024 Annual Financial Results
Newsfile
InsuJet Distribution Expands Across Canada
AI-generated - The Globe and Mail
NuGen Medical Devices: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (NGMD)
AI-generated - The Globe and Mail
NuGen Medical Devices: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (NGMD)
AI-generated - The Globe and Mail
NuGen Medical Devices: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (NGMD)
Newsfile
NuGen Announces the Appointment of Liang Lin as Chief Executive Officer
AI-generated - The Globe and Mail
NuGen Medical Devices: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (NGMD)
AI-generated - The Globe and Mail
NuGen Medical Devices: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (NGMD)
Newsfile
NuGen Announces Canada-Wide Launch of InsuJet
Newsfile
NuGen Announces Results of Special Meeting and Appointment of New Directors
AllPennyStocks.com
Medical Device Company Soaring on Strategic Partnership for Needle-Free Insulin Injector
Medical Device Company Soaring on Strategic Partnership for Needle-Free Insulin Injector
Newsfile
NuGen Announces Strategic Partnership with EziAutoJector Limited
Newsfile
NuGen Announces Closing of Private Placement of $10 million Secured Convertible Debentures
AI-generated - The Globe and Mail
NuGen Medical Devices: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (NGMD)
Newsfile
NuGen Announces Release of Financial Results for Q2 2024 & Update on Proposed Private Placement
Newsfile
NuGen Announces Voting Results of Annual and Special Meeting
Newsfile
NuGen Announces Revised Terms of Proposed Private Placement of up to $10 Million Secured Convertible Debentures
Newsfile
NuGen Receives Order for Repeat Demand in Mexico
Newsfile
NuGen Announces Proposed Private Placement of up to $10 million Secured Convertible Debentures
Newsfile
NuGen Develops Pharmacist Training Packages for the Canadian Retail Pharmacy Market
Newsfile
NuGen Announces Completion of InsuJet(TM) Training with Sol-Millennium(TM) Brazil
Newsfile
NuGen Announces Repeat Order for Growing InsuJet(TM) Demand in Yemen

Profile

NuGen Medical Devices Inc is a medical device manufacturing company specializing in the field of needleless injections and related technologies. The reportable segment of the company is the manufacturing of needle injector devices. Geographically, the company generates revenue from Europe, followed by Asia, North America, and other.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.